| Cancer | CancerType | Treatment | Signature | SearchID | Experimental | PMID | Details | Boxplot | Network | Correlation | Survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuroblastoma | NB | BLZ945 | CSF-1R | CSF1R | clinical trail | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | T cells | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | TIL | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | macrophages | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | MDSCs | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | macrophages | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | MDSCs | NA | Mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | PD-L1 | CD274 | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | CSF-1R | CSF1R | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | PD-L1 | CD274 | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | CSF-1R | CSF1R | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | CXCL9 | CXCL9 | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | CXCL10 | CXCL10 | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |
| Neuroblastoma | NB | nivolumab | CXCL11 | CXCL11 | mouse model | 28123870 | Details | ![]() | ![]() | ![]() | ![]() |



